Sangamo Files To Raise Capital (SGMO)

SANGAMO BIOSCIENCES, INC. (NASDAQ: SGMO) has filed to raise capital.  The company filed with the SEC on Wednesday night to raise up to $100 million with the sale of any combination of the following securities: Common Stock; Preferred Stock; Debt Securities; Warrants to Purchase Common Stock; and/or Warrants to Purchase Preferred Stock.

This was a shelf filing so no underwriters were named.  The use of proceeds is listed as the traditional “general corporate purposes” and that includes “support for continuing research and development, commercialization activities, business development activities, and potential acquisitions of businesses, products, technologies or licenses that are complementary to Sangamo’s business.

The company did specify that it has no current plans, commitments or agreements with respect to any acquisitions.

Before the effects of any offering, Yahoo! Finance noted a market capitalization rate of $297.5 million.  At $5.67, the 52-week trading range is $2.36 to $9.15 and the average daily trading volume is roughly 385,000 shares.